Jose Tomas Ramos Amador
AuthID: R-00K-W01
1
TÃTULO: Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically- suppressed children and adolescents living with HIV-Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial
AUTORES: Compagnucci, Alexandra; Chan, Man K.; Saidi, Yacine; Cressey, Tim R.; Bamford, Alasdair; Riault, Yoann; Coelho, Alexandra; Nolan, Aoife; Chalermpantmetagul, Suwalai; Morkunaite, Gabija; Amuge, Pauline; Musiime, Victor; Violari, Avy; Cotton, Mark; Kekitiinwa, Adeodata R.; Kaudha, Elizabeth; Groenewald, Marisa; Liberty, Afaaf A.; Kanjanavanit, Suparat; Volokha, Alla; ...Mais
PUBLICAÇÃO: 2023, FONTE: ECLINICALMEDICINE, VOLUME: 60
AUTORES: Compagnucci, Alexandra; Chan, Man K.; Saidi, Yacine; Cressey, Tim R.; Bamford, Alasdair; Riault, Yoann; Coelho, Alexandra; Nolan, Aoife; Chalermpantmetagul, Suwalai; Morkunaite, Gabija; Amuge, Pauline; Musiime, Victor; Violari, Avy; Cotton, Mark; Kekitiinwa, Adeodata R.; Kaudha, Elizabeth; Groenewald, Marisa; Liberty, Afaaf A.; Kanjanavanit, Suparat; Volokha, Alla; ...Mais
PUBLICAÇÃO: 2023, FONTE: ECLINICALMEDICINE, VOLUME: 60
INDEXADO EM: 
Scopus 
WOS
Scopus WOS